{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:14:31Z","timestamp":1789751671014,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK7989S"],"award-info":[{"award-number":["DK7989S"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM078114"],"award-info":[{"award-number":["GM078114"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-14682"],"award-info":[{"award-number":["MOP-14682"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.jmb.2010.05.001","type":"journal-article","created":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T04:31:31Z","timestamp":1273293091000},"page":"555-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["The Sulfated Triphenyl Methane Derivative Acid Fuchsin Is a Potent Inhibitor of Amyloid Formation by Human Islet Amyloid Polypeptide and Protects against the Toxic Effects of Amyloid Formation"],"prefix":"10.1016","volume":"400","author":[{"given":"Fanling","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andisheh","family":"Abedini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Plesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris T.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin T.","family":"Zanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Bruce","family":"Verchere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Raleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2010.05.001_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/10408369409084679","article-title":"Amyloidosis","volume":"31","author":"Sipe","year":"1994","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.jmb.2010.05.001_bib2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","article-title":"Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases","volume":"6","author":"Selkoe","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jmb.2010.05.001_bib3","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.05.001_bib4","doi-asserted-by":"crossref","unstructured":"Cooper, G. J. S., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B. & Reid, K. B. M. (1987). Purification and characterization of a peptide from amyloid-rich pancreases of type-2 diabetic-patients. Proc. Natl Acad. Sci. USA, 84, 8628\u20138632.","DOI":"10.1073\/pnas.84.23.8628"},{"key":"10.1016\/j.jmb.2010.05.001_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diabetes.48.2.241","article-title":"Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes","volume":"48","author":"Kahn","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.05.001_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(87)90825-7","article-title":"Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes","volume":"2","author":"Clark","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2010.05.001_bib7","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","author":"Hull","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jmb.2010.05.001_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0531-5565(03)00004-4","article-title":"Islet amyloid polypeptide and type 2 diabetes","volume":"38","author":"Marzban","year":"2003","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jmb.2010.05.001_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","article-title":"A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas","volume":"140","author":"Westermark","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmb.2010.05.001_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/jmbi.2001.4593","article-title":"Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis","volume":"308","author":"Jaikaran","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2010.05.001_bib11","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1210\/endo.135.4.7925129","article-title":"Developmental Expression of the prohormone convertases Pc1 and Pc2 in mouse pancreatic-islets","volume":"135","author":"Marcinkiewicz","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.jmb.2010.05.001_bib12","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1073\/pnas.94.13.6646","article-title":"Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2","volume":"94","author":"Furuta","year":"1997","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.05.001_bib13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","article-title":"The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site","volume":"50","author":"Wang","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.05.001_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diabetes.53.1.141","article-title":"Role of beta-cell prohormone convertase (PC) 1\/3 in processing of pro-islet amyloid polypeptide","volume":"53","author":"Marzban","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.05.001_bib15","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.2337\/db07-1842","article-title":"Islets in type 2 diabetes: in honor of Dr. Robert C. Turner","volume":"57","author":"Bonner-Weir","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.05.001_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00265542","article-title":"The insulin secretory granule","volume":"32","author":"Hutton","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.jmb.2010.05.001_bib17","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1016\/S0021-9258(19)39539-0","article-title":"Islet amyloid polypeptide\u2014a new beta-cell secretory product related to islet amyloid deposits","volume":"265","author":"Nishi","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2010.05.001_bib18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","article-title":"Pancreatic-islet cell toxicity of amylin associated with type-2 diabetes-mellitus","volume":"368","author":"Lorenzo","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2010.05.001_bib19","first-page":"151","article-title":"Islet amyloid, increased alpha cells, reduced beta cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes","volume":"9","author":"Clark","year":"1988","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jmb.2010.05.001_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01660981","article-title":"Immunohistology of islet amyloid polypeptide in diabetes-mellitus\u2014semiquantitative studies in a postmortem series","volume":"421","author":"Rocken","year":"1992","journal-title":"Virchows Arch. A: Pathol. Anat. Histopathol."},{"key":"10.1016\/j.jmb.2010.05.001_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.05.001_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/edrv-15-2-163","article-title":"Amylin compared with calcitonin-gene-related peptide\u2014structure, biology, and relevance to metabolic disease","volume":"15","author":"Cooper","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jmb.2010.05.001_bib23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMc0802893","article-title":"Widespread amyloid deposition in transplanted human pancreatic islets","volume":"359","author":"Westermark","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2010.05.001_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/2000-1967-113","article-title":"Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice","volume":"108","author":"Westermark","year":"2003","journal-title":"Upsala J. Med. Sci."},{"key":"10.1016\/j.jmb.2010.05.001_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00125-008-1185-7","article-title":"Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets","volume":"52","author":"Udayasankar","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jmb.2010.05.001_bib26","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1073\/pnas.0909024107","article-title":"Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts","volume":"107","author":"Potter","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.05.001_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/npp.2008.151","article-title":"Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles","volume":"34","author":"Blazer","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jmb.2010.05.001_bib28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1021\/ar8000475","article-title":"Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation","volume":"41","author":"Takahashi","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jmb.2010.05.001_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nchembio.65","article-title":"Small-molecule aggregates inhibit amyloid polymerization","volume":"4","author":"Feng","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jmb.2010.05.001_bib30","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1021\/ja072157y","article-title":"A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor","volume":"129","author":"Abedini","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2010.05.001_bib31","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0507471103","article-title":"Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis","volume":"103","author":"Yan","year":"2006","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.05.001_bib32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10989-004-2423-6","article-title":"Inhibitors of islet amyloid polypeptide fibrillogenesis, and the treatment of type-2 diabetes","volume":"10","author":"Scrocchi","year":"2003","journal-title":"Lett. Pept. Sci."},{"key":"10.1016\/j.jmb.2010.05.001_bib33","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1021\/bi048582a","article-title":"Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions","volume":"43","author":"Porat","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2010.05.001_bib34","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1002\/anie.200705372","article-title":"Small-molecule inhibitors of islet amyloid polypeptide fibril formation","volume":"47","author":"Mishra","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jmb.2010.05.001_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","article-title":"Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism","volume":"67","author":"Porat","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmb.2010.05.001_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13506129509031881","article-title":"Thioflavine-T interaction with amyloid beta-sheet structures","volume":"2","author":"Levine","year":"1995","journal-title":"Amyloid: Int. J. Exp. Clin. Invest."},{"key":"10.1016\/j.jmb.2010.05.001_bib37","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1021\/bi702518m","article-title":"Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril thioflavin-T interactions: implications for mechanistic studies of beta-cell death","volume":"47","author":"Meng","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2010.05.001_bib38","doi-asserted-by":"crossref","first-page":"15679","DOI":"10.1021\/jp9072203","article-title":"Strategies for extracting structural information from 2D IR spectroscopy of amyloid: application to islet amyloid polypeptide","volume":"113","author":"Strasfeld","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmb.2010.05.001_bib39","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1021\/ja801483n","article-title":"Tracking fiber formation in human islet amyloid polypeptide with automated 2D-IR Spectroscopy","volume":"130","author":"Strasfeld","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2010.05.001_bib40","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1073\/pnas.0805957106","article-title":"Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution","volume":"106","author":"Shim","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.05.001_bib41","doi-asserted-by":"crossref","first-page":"17751","DOI":"10.1073\/pnas.0909888106","article-title":"2D IR provides evidence for mobile water molecules in beta-amyloid fibrils","volume":"106","author":"Kim","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.05.001_bib42","doi-asserted-by":"crossref","first-page":"14197","DOI":"10.1073\/pnas.0700804104","article-title":"Automated 2D IR spectroscopy using a mid-IR pulse shaper and application of this technology to the human islet amyloid polypeptide","volume":"104","author":"Shim","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.05.001_bib43","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1021\/jp810261x","article-title":"Two-dimensional infrared spectroscopy provides evidence of an intermediate in the membrane-catalyzed assembly of diabetic amyloid","volume":"113","author":"Ling","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmb.2010.05.001_bib44","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1073\/pnas.0802993105","article-title":"Two-dimensional infrared spectra of isotopically diluted amyloid fibrils from A beta 40","volume":"105","author":"Kim","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.05.001_bib45","doi-asserted-by":"crossref","first-page":"18349","DOI":"10.1073\/pnas.0806270105","article-title":"Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils","volume":"105","author":"Paravastu","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.05.001_bib46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2174\/156720507781788882","article-title":"Alzhemed: a potential treatment for Alzheimer's disease","volume":"4","author":"Aisen","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jmb.2010.05.001_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0295-143","article-title":"Arresting amyloidosis in vivo using small-molecule anionic sulfonates or sulfates\u2014implications for Alzheimer's disease","volume":"1","author":"Kisilevsky","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmb.2010.05.001_bib48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neurobiolaging.2006.02.015","article-title":"Targeting soluble A beta peptide with Tramiprosate for the treatment of brain amyloidosis","volume":"28","author":"Gervais","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jmb.2010.05.001_bib49","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMe078027","article-title":"Advances in the treatment of amyloidosis","volume":"356","author":"Rajkumar","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2010.05.001_bib50","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa065644","article-title":"Eprodisate for the treatment of renal disease in AA amyloidosis","volume":"356","author":"Dember","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2010.05.001_bib51","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/diabetes.47.4.612","article-title":"Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation","volume":"47","author":"Castillo","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.05.001_bib52","doi-asserted-by":"crossref","first-page":"31617","DOI":"10.1074\/jbc.272.50.31617","article-title":"Heparin-binding properties of the amyloidogenic peptides A beta and amylin\u2014dependence on aggregation state and inhibition by Congo red","volume":"272","author":"Watson","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2010.05.001_bib53","doi-asserted-by":"crossref","first-page":"16284","DOI":"10.1021\/bi051432v","article-title":"The role of His-18 in amyloid formation by human islet amyloid polypeptide","volume":"44","author":"Abedini","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2010.05.001_bib54","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/anie.200604056","article-title":"IAPP mimic blocks A beta cytotoxic self-assembly: Cross-suppression of amyloid toxicity of A beta and IAPP suggests a molecular link between Alzheimer's disease and type II diabetes","volume":"46","author":"Yan","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jmb.2010.05.001_bib55","doi-asserted-by":"crossref","first-page":"17490","DOI":"10.1074\/jbc.M311300200","article-title":"Seeding specificity in amyloid growth induced by heterologous fibrils","volume":"279","author":"O'Nuallain","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2010.05.001_bib56","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1021\/ol047480+","article-title":"Incorporation of pseudoproline derivatives allows the facile synthesis of human IAPP, a highly amyloidogenic and aggregation-prone polypeptide","volume":"7","author":"Abedini","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/j.jmb.2010.05.001_bib57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ab.2005.11.029","article-title":"Recovery and purification of highly aggregation-prone disulfide-containing peptides: application to islet amyloid polypeptide","volume":"351","author":"Abedini","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jmb.2010.05.001_bib58","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1039\/B813817F","article-title":"How to turn your pump-probe instrument into a multidimensional spectrometer: 2D IR and Vis spectroscopies via pulse shaping","volume":"11","author":"Shim","year":"2009","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jmb.2010.05.001_bib59","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1364\/OL.31.000838","article-title":"Femtosecond pulse shaping directly in the mid-IR using acousto-optic modulation","volume":"31","author":"Shim","year":"2006","journal-title":"Opt. Lett."},{"key":"10.1016\/j.jmb.2010.05.001_bib60","doi-asserted-by":"crossref","first-page":"13120","DOI":"10.1364\/OE.14.013120","article-title":"Generation and characterization of phase and amplitude shaped femtosecond mid-IR pulses","volume":"14","author":"Shim","year":"2006","journal-title":"Opt. Express"}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283610004675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283610004675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T21:11:33Z","timestamp":1758316293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283610004675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0022283610004675"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2010.05.001","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Sulfated Triphenyl Methane Derivative Acid Fuchsin Is a Potent Inhibitor of Amyloid Formation by Human Islet Amyloid Polypeptide and Protects against the Toxic Effects of Amyloid Formation","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2010.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}